Signaling Pathway
Eluvixtamab is a monoclonal antibody that targets both CD3E and CD33 antigens. This dual specificity enables it to engage T cells and myeloid cells simultaneously, making it a valuable tool for research into immune cell interactions and potential therapeutic applications in diseases characterized by aberrant myeloid cell activity.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Eluvixtamab is a monoclonal antibody that targets both CD3E and CD33 antigens. This dual specificity enables it to engage T cells and myeloid cells simultaneously, making it a valuable tool for research into immune cell interactions and potential therapeutic applications in diseases characterized by aberrant myeloid cell activity. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
